TRUALT BIOENERGY LIMITED Fair Value
TRUALT · Fast Moving Consumer Goods · Current price ₹423.85
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹164 | 8% ROE fading to 14% over ~3 yrs, on ₹177 book |
| Relative P/E | ₹452 | EPS × 40.4 peer-median P/E |
| Graham floor | ₹211 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is TRUALT BIOENERGY LIMITED undervalued?
DocStoX estimates the fair value of TRUALT BIOENERGY LIMITED at ₹252 per share, versus the current market price of ₹424. That puts the stock about -40.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹164), Relative P/E (₹452), Graham floor (₹211). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹164 (bear) to ₹252 (base) to ₹452 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on TRUALT BIOENERGY LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.